The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Skin cancer 2
Rituximab Small intestinal obstruction 2
RITUXIMAB Spinal corpectomy 2
Rituximab Spinal disorder 2
Rituximab Squamous cell carcinoma of lung 2
RITUXIMAB Status epilepticus 2
RITUXIMAB Streptococcal infection 2
Rituximab Stress cardiomyopathy 2
Rituximab Swelling face 2
RITUXIMAB Systemic candida 2
RITUXIMAB Throat irritation 2
Rituximab Transitional cell carcinoma 2
Rituximab Tumour flare 2
RITUXIMAB Urinary retention 2
Rituximab Urinary tract infection pseudomonal 2
RITUXIMAB Vascular dementia 2
RITUXIMAB Vertebral body replacement 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Abdominal discomfort 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Abdominal pain 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Atrial fibrillation 2

Total Records: 1,104     Number of Pages: 56